Recruiting

Testing a new antibacterial wound dressing for diabetic foot ulcers

Plain-English translation of NCT06667752 on ClinicalTrials.gov ↗ · Source last updated August 2025 · Translation generated June 2026 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

This trial is testing Nanordica Advanced Antibacterial Wound Dressing, a new type of bandage designed to help diabetic foot ulcers heal. About 170 people with diabetic foot ulcers will be randomly assigned to receive either this medication or a standard antibacterial dressing. The study will compare how well each dressing works and how safe it is over a 12-week period.

Diabetic foot ulcers are serious wounds that can take a long time to heal and often become infected. Researchers want to see if this new treatment can help these wounds heal faster and prevent infection better than dressings currently in use.

Do you qualify?

You likely qualify if…

you have a diabetic foot ulcer that has been present for more than 4 weeks
your ulcer is no larger than 4 centimeters across
you have little to no infection in the wound, or only mild infection
you have adequate blood flow to your foot (measured by an ankle-brachial index test)
you are 18 years or older and willing to attend all study visits

You likely don't qualify if…

you have taken antibiotics by mouth or applied them to the wound in the past week
your ulcer has bone infection or shows signs of reaching the bone
you have had recent surgery on the same leg within the past four weeks
you have severe heart, liver, or advanced cancer conditions
you are pregnant, breastfeeding, or not using adequate birth control

What participation looks like

You will be randomly assigned to receive either the new antibacterial dressing or a standard dressing for 4 weeks. During this first phase, your wound will be dressed with your assigned treatment and monitored regularly. After 4 weeks, you will continue with standard wound care for another 8 weeks while researchers track how well your ulcer is healing. You will need to attend scheduled visits and have your wound assessed throughout the 12-week study.

AI-generated summary from trial data · Jun 1, 2026 · Not medical advice

Trial locations(11 sites)

Estonia

East Tallinn Central Hospital, Tallinn, Harju

North Estonia Medical Centre Foundation, Tallinn, Harju

Tartu University Hospital, Tartu, Tartu

Spain

Centro de Salud de Arcos de la Frontera, Arcos de la Frontera, Cádiz

Hospital Puerta del Mar, Cadiz, Cádiz